Materials and methods Patients diagnosed with COVID-19 associated mucormycosis were
followed up for 6 months to study the clinical profile, readmissions, long-term treatment …

Background Mucormycosis has been identified with increasing frequency in patients with
coronavirus disease 2019 (COVID-19). Aims We aimed to determine the in-hospital outcome …

Abstract Coronavirus disease of 2019 (COVID-19) predisposes patients to invasive fungal
infections. Data on clinical characteristics and outcomes of COVID-19 patients with …

Methods: A retrospective data analysis of all proven mucormycosis cases among COVID-19
infected patients from September 1, 2020 to December 31, 2020, was carried out after …

Abstract Background and Objective: Mucormycosis, a serious and rare fungal infection, has
occurred concurrently in COVID-19 patients globally. Mucormycosis is associated with a …

Recently, a fungal disease,“Mucormycosis,” has created a huge fury in everybody's mind. It
is prevalent in immunocompromised individuals, such as people suffering from Covid 19 …

Background:-The sharp uptick in the cases of mucormycosis in the background of the
COVID19 pandemic is a cause of concern and the reasons and it's impact remains to be …

Abstract Poster session 3, September 23, 2022, 12: 30 PM-1: 30 PM Objectives Coronavirus
disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 …

Objective: To compare COVID-19 associated mucormycosis cases (CAM) with non-COVID-
19 associated mucormycosis (non-CAM) cases followed as in-patients. Study Design …

Objective: To explore risk factors of mucormycosis in COVID-19 recovered patients.
Methods: A total of 101 patients, who were diagnosed with mucormycosis after recovery from …